Senior Faculty Scholars

Dr. Lengyel is a gynecologic oncologist who is board certified in general gynecology and gynecologic oncology. He attended medical school at the University of Munich and went to the University of Munich, UCSF, and Stanford for postgraduate training. In 2003, Dr. Lengyel joined the faculty of the University of Chicago. Since that time he has established a clinical practice specializing in radical debulking surgery for ovarian cancer and a translational research laboratory focused on understanding ovarian cancer biology. Recently, his group elucidated how adipocyte/cancer cell interactions promote ovarian cancer metastasis through the metabolic reprogramming of tumor cells. They have also shown that mesothelial cells play a critical role in ovarian cancer metastasis.

Dr. Lengyel has published over 90 peer-reviewed papers, including contributions to Nature, Nature Medicine, JCI, Oncogene, JBC, and Cancer Research. He is also the author of the chapter on ovarian cancer in the current edition of Principles and Practice of Gynecologic Oncology, the standard textbook of the specialty Dr. Lengyel holds 2 RO1 grants, a Burroughs Wellcome Award in translational research, and several other grants from private foundations, including a PPG planning grant from the Ovarian Cancer Research Fund. He is an ad hoc member of NIH study sections.

Dr. Lengyel is the Arthur L. and Lee G. Herbst Professor of Obstetrics and Gynecology and is the Chair of the Department of Obstetrics and Gynecology at the University of Chicago.

Stacie Levine, MD, specializes in geriatric medicine and palliative care with a focus on pain management. She strives to provide the highest level of support to patients and their families during transitions in care.

In addition to her clinical responsibilities, Dr. Levine is a dedicated educator. Under her leadership, fellows learn how to recognize and effectively manage pain, as well as how to foster important conversations about prognosis during end-of-life care.

Dr. Levine has contributed to leading textbooks on the role of palliative medicine in chronic illnesses. She also serves as a reviewer for several prominent scientific journals, including Journal of Hospital Medicine and American Journal of Medicine.

Christina Lewicky-Gaupp, MD, FACOG, FACS, is an expert urogynecologist and reconstructive pelvic surgeon. Dr. Lewicky-Gaupp’s practice emphasizes a patient-centered, individualized approach to diagnose and treat pelvic health issues, such as pelvic organ prolapse, urinary incontinence, fecal incontinence, maternal birth trauma and urogenital fistulas. Using advanced treatment options, she strives to provide the most effective and efficient treatments for these complex, personal conditions. With compassion and understanding, Dr. Lewicky-Gaupp works with each patient to develop the best possible solution.

Dr. Lewicky-Gaupp’s research has focused on clinical outcomes trials as well as the optimization of treatment of maternal birth trauma. In addition to being dedicated to her patients, Dr. Lewicky-Gaupp is a passionate educator who has received multiple awards for outstanding teaching. In addition to a lifelong career of teaching medical students, residents and fellows in the clinic and operating room, she has served as an Associate Residency and Fellowship Program Director and is currently the Program Director of the Urogynecology and Reconstructive Pelvic Surgery Fellowship at the University of Chicago.

Dr. Stanley Liauw serves as the Director of Clinical Operations and is the clinical lead for the genitourinary (GU) cancer program, and the gastrointestinal (GI) cancer program within the Department of Radiation and Cellular Oncology at the University of Chicago. In the past 10 years on faculty, Dr. Liauw has developed research programs in these disease sites, with an interest in outcomes research and clinical trials. The central mission of his research is to conduct clinical studies to define current clinical outcomes and areas of need, develop hypotheses, and test novel regimens to reduce the morbidity or mortality of radiation therapy in the treatment of cancer.

A major focus of Dr. Liauw’s efforts include the periodic analysis and reporting of cancer outcomes with radiation therapy. This work, derived from multiple institutional databases of more than 2000 patients, has resulted in numerous abstract presentations and publications in peer-reviewed journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology, Biology, Physics and Cancer. These contributions generally fall into 3 categories of interest: presenting hypotheses to improve the therapeutic ratio of therapy, studying the use of imaging in radiation oncology, and exploring potential markers of response to therapy.

A number of clinical protocols have been opened for patients with genitourinary and gastrointestinal cancers. Dr. Liauw has investigated and initiated trials for a: phase I study of dose escalated stereotactic body RT trial for unresectable pancreatic cancer, phase II quality of life study of oral hormonal therapy with RT for prostate cancer, phase I study for oligometastatic renal cell cancer, and phase I randomized study for hepatocellular carcinoma treated with RT and immunotherapy.

Outside of his research interests, Dr. Liauw has overseen several intradepartmental projects aimed at improving clinical workflow and patient safety, with potential downstream effects on patient and employee satisfaction. He served as the clinical lead for the implementation of intraoperative radiation therapy in 2015, as an Associate Editor for GI cancers for the International Journal of Radiation Oncology, Biology, and Physics, as an examiner and question writer for the American Board of Radiology for GU cancers, and an invited speaker for national and international educational lectures such as through the American Society of Radiation Oncology (ASTRO) and the American Urological Association. He has been an invited Visiting Professor for resident education at multiple institutions, and has been regularly recognized from the University of Chicago training program as a top educator. He has been an ad hoc reviewer of manuscripts for more than 20 scientific journals, including Journal of Clinical Oncology and the New England Journal of Medicine.

An expert in the fields of population health and sexuality, Stacy Lindau is a practicing gynecologist and physician scientist who focuses on the health and life course of women and people living in poverty. She uses a community-engaged approach, working together with the patients and populations she serves to solve big health problems.

Lindau is the director of the Program in Integrative Sexual Medicine and WomanLab, an effort that aims to educate the public on preserving and restoring sexual function in women affected by cancer and other common health conditions. She also directs the South Side Health and Vitality Studies, including Feed1st, a hospital-based hunger mitigation effort and is President of MAPSCorps, a non-profit organization spun out of her lab that conducts an annual, comprehensive community asset census together with youth from high poverty communities across the U.S.

Lindau is an NIH-funded investigator since 2005 and has published extensively in the highest impact medical journals. She was awarded a 2016–18 Aspen Health Innovators Fellowship and is a member of the Aspen Global Leadership Network.

Dr. Hue H. Luu is a professor of Orthopaedic Surgery and Rehabilitation Medicine and the Associate Director of the molecular oncology lab. Dr. Luu attend the Pritzker School of Medicine and completed his internship, residency, and fellowship at University of Chicago Medicine.Dr. Luu specializes in hip and knee replacements as well as the surgical care of bone and soft tissue tumors. He is an expert in both direct anterior approach and mini-posterior approach total hip replacements. Direct anterior approach total hip replacement is a more muscle sparing and less invasive technique that allows for a more rapid recovery.

Dr. Luu also uses the state of the art Robotic Arm Assisted technology for total hip, total knee, and partial knee replacement surgeries. Robotic assistance allows for more precision and less soft tissue damage. He strives to give outstanding care to his patients to help restore their quality of life and function. Dr. Luu works with a multidisciplinary physician team to provide comprehensive care for patients with benign and malignant musculoskeletal tumors.

Dr. Luu’s research interests include the fundamental mechanisms regulating bone biology and bone regeneration as well as outcomes research in total joint replacement patients.

Dr. Mak has expertise in providing surgical care for children of all ages. She specializes in the surgical treatment of neonatal diseases and congenital malformations, anorectal malformations, inflammatory bowel disease, and pediatric oncology. Dr. Mak is also highly skilled in pediatric minimally invasive surgery.

Her academic interests include surgical education, particularly involving the pediatric surgical fellows. As the Program Director of the Pediatric Surgery Fellowship, she has worked with many national committees to improve the education of pediatric surgical fellows and develop the new Milestones for Pediatric Surgery.

Dr. Mak’s research interests include advancement in minimally invasive techniques, innovations in surgical education, and health care disparities. Specifically, she is currently developing a curriculum for the families and care givers of patients with complex anorectal and colorectal malformations. The goal is to improve the education and understanding of these families to provide not only better overall patient care but also enhance the physician patient relationship and allow the families more autonomy.

Dr. Monica Malec is an Associate Professor of Medicine and Director of Palliative Medicine clinical programs in the section of Geriatrics and Palliative Medicine. She received her medical degree from the University of Illinois at Chicago College of Medicine and completed her Internal Medicine training at Rush University Medical Center. Dr. Malec is board-certified in Hospice and Palliative Medicine and is a fellow of the American Academy of Hospice and Palliative Medicine. An expert in the management of complex pain and non-pain symptoms, she strives to support patients throughout the trajectory of their illness to achieve the best possible quality of life.

Dr. Malec is a University of Chicago Center for Healthcare Delivery Science and Innovation Scholar focused on improving processes for advance care planning and communication with patients about their values and preferences for care. She is working to create educational programs to develop communication skills around serious illness for providers at all levels to promote goal-concordant care for patients.

Dr. Marcangelo is a consultation-liaison psychiatrist and psychiatric educator. He joined the Department of Psychiatry and Behavioral Neuroscience in 2008 and has served as the Director of Medical Student Education in Psychiatry ever since. In this role, he directs the psychiatric clerkship and is the director of the Human Behavior in Health and Illness course for second year Pritzker students. He has researched the use of Objective Structured Clinical Examinations in psychiatric evaluation. He is also a founding member of the Clinical Skills Initiative Taskforce for the Association of Directors of Medical Student Education in Psychiatry. In this role he has participated in the development of nearly a dozen clinical modules that are being used internationally to facilitate psychiatric education of medical students. Clinically, Dr. Marcangelo has served on the inpatient psychiatry consult service at the University of Chicago since 2008, each year providing over 500 psychiatric consultations for patients in the hospital. He has also served as the director of the transplant psychiatry program and evaluates approximately 100 transplant candidates each year. He has worked with the liver transplant team and currently works with the kidney, heart, and lung transplant teams. He also maintains an active psychotherapy practice.

In 2020, Dr. Marcangelo joined the faculty a Northwestern University.

Dr. John McConville is an Associate Professor of Medicine and the Vice Chair for Education in the Department of Medicine at the University of Chicago. He earned his undergraduate degree in Philosophy from the University of Notre Dame and completed his medical degree at Penn State University. He then returned to the Midwest for internal medicine and Pulmonary/Critical Care fellowship training at the University of Chicago.

During his fellowship and as a junior faculty member, Dr. McConville researched the role of airway smooth muscle in the pathogenesis of asthma and the interactions between obesity and asthma. Over the past 15 years, he has focused on clinical practice and medical education. He served as the program director for the Pulmonary and Critical Care fellowship program before becoming the Internal Medicine residency program director, a role he has held for the past decade.

As Vice Chair for Education, Dr. McConville is dedicated to advancing medical education and has a particular passion for teaching residents how to incorporate bedside ultrasound into their daily practice. He is actively involved in the Alliance for Academic Internal Medicine (AAIM), where he has contributed to various committees aimed at improving transitions across the medical education continuum. Additionally, he co-leads the University Assembly of Internal Medicine program directors.

Dr. McConville’s commitment to medical education and his extensive experience in clinical practice and program leadership make him a valuable asset to the University of Chicago and the broader medical community.